Physalin A exerts neuroprotective effects: inhibition of OGD/R-induced cellular pyroptosis and inflammatory responses in nerve cells

A prevalent cerebrovascular disease like the acute cerebral infarction is caused by cerebral thrombosis or arteriosclerosis that can result in ischemic necrosis of brain tissues. Treatment drugs of higher efficiency are required to be developed for acute cerebral infarction. Physalin A (PA) is a major compound from Physalis alkekengi L. and has pharmacological properties. However, the neuroprotective effects of PA are less reported and the mechanism remains unclear. The acute cerebral infarction cell model was constructed by treating PC12 cells with oxygen-glucose deprivation/reoxygenation (OGD/R). The impacts of PA on cell viability were determined by performing 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide (MTT) and lactate dehydrogenase (LDH) releasing assays. Immunoblot and Enzyme-linked Immunosorbent assay (ELISA) were conducted to examine PA effects on inflammation. PA effects on pyroptosis were detected by performing immunoblot and immunostaining. Moreover, immunoblot was further conducted to confirm the mechanism. In this study, the survival and inhibition of the pyroptosis of OGD/R-induced PC12 cells were regulated by PA. Furthermore, PA suppressed the inflammation. PA inhibited mitogen-activated protein kinase (MAPK) pathway activation, and the activation of MAPK pathway reversed the neuroprotective effect of PA. Therefore, PA exerts neuroprotective effects by suppressing OGD/R-induced cellular pyroptosis and inflammatory responses in nerve cells.

Acute cerebral infarction; Physalin A (PA); OGD/R; Pyroptosis; MAPK pathway

[1] Edwards MD, Hughes TAT. Managing blood pressure in acute cerebral infarction. Journal of Neurology. 2021; 268: 2294–2296.

[2] Ren K, Liu W, Tian J, Zhang Y, Peng J, Zhang D, et al. Mitochondrial E3 ubiquitin ligase 1 promotes brain injury by disturbing mitochondrial dynamics in a rat model of ischemic stroke. European Journal of Pharmacology. 2019; 861: 172617.

[3] Ren KD, Peng ZM, Tian J, Peng YW, Zhang YY, Zhang XJ, et al. Dipsacoside B exerts a beneficial effect on brain injury in the ischemic stroke rat through inhibition of mitochondrial E3 ubiquitin ligase 1. CNS & Neurological Disorders Drug Targets. 2022; 21: 693–703.

[4] Henein MY, Vancheri S, Longo G, Vancheri F. The role of inflammation in cardiovascular disease. International Journal of Molecular Sciences. 2022; 23: 12906.

[5] Luan Y, Ren KD, Luan Y, Chen X, Yang Y. Mitochondrial dynamics: pathogenesis and therapeutic targets of vascular diseases. Frontiers in Cardiovascular Medicine. 2021; 8: 770574.

[6] Li A, Chen B, Li G, Zhou M, Li Y, Ren D, et al. Physalis alkekengi L. var. franchetii (Mast.) Makino: an ethnomedical, phytochemical and pharmacological review. Journal of Ethnopharmacology. 2018; 210: 260–274.

[7] Lu R, Yu X, Liang S, Cheng P, Wang Z, He ZY, et al. Physalin A Inhibits MAPK and NF-kB signal transduction through integrin alphaVbeta3 and exerts chondroprotective effect. Frontiers in Pharmacology. 2021; 12: 761922.

[8] Marahatha R, Gyawali K, Sharma K, Gyawali N, Tandan P, Adhikari A, et al. Pharmacologic activities of phytosteroids in inflammatory diseases: mechanism of action and therapeutic potentials. Phytotherapy Research. 2021; 35: 5103–5124.

[9] Wang L, Gu J, Zong M, Zhang Q, Li H, Li D, et al. Anti-inflammatory action of physalin A by blocking the activation of NF-kB signaling pathway. Journal of Ethnopharmacology. 2021; 267: 113490.

[10] Lin Y, Hsiao Y, Ng K, Kuo Y, Lim Y, Hsieh W. Physalin a attenuates inflammation through down-regulating c-Jun NH2 kinase phosphorylation/Activator Protein 1 activation and up-regulating the antioxidant activity. Toxicology and Applied Pharmacology. 2020; 402: 115115.

[11] Kloner RA, King KS, Harrington MG. No-reflow phenomenon in the heart and brain. American Journal of Physiology-Heart and Circulatory Physiology. 2018; 315: H550–H562.

[12] Diener H, Easton JD, Hart RG, Kasner S, Kamel H, Ntaios G. Review and update of the concept of embolic stroke of undetermined source. Nature Reviews Neurology. 2022; 18: 455–465.

[13] Ji L, Yuan Y, Luo L, Chen Z, Ma X, Ma Z, et al. Physalins with anti-inflammatory activity are present in Physalis alkekengi var. franchetii and can function as Michael reaction acceptors. Steroids. 2012; 77: 441–447.

[14] Lu R, Xu H, Deng X, Wang Y, He Z, Xu S, et al. Physalin a alleviates intervertebral disc degeneration via anti-inflammatory and anti-fibrotic effects. Journal of Orthopaedic Translation. 2023; 39: 74–87.

[15] Coll RC, Schroder K, Pelegrín P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends in Pharmacological Sciences. 2022; 43: 653–668.

[16] Li N, Wang Y, Wang X, Sun N, Gong Y. Pathway network of pyroptosis and its potential inhibitors in acute kidney injury. Pharmacological Research. 2022; 175: 106033.

[17] Shi M, Chen J, Liu T, Dai W, Zhou Z, Chen L, et al. Protective effects of remimazolam on cerebral ischemia/reperfusion injury in rats by inhibiting of NLRP3 inflammasome-dependent pyroptosis. Drug Design, Development and Therapy. 2022; 16: 413–423.

[18] Ni WW, Zhang QM, Zhang X, Li Y, Yu SS, Wu HY, et al. Modulation effect of Lactobacillus acidophilus KLDS 1.0738 on gut microbiota and TLR4 expression in β-lactoglobulin-induced allergic mice model. Allergologia Et Immunopathologia. 2020; 48: 149–157.

[19] Liu Z, Yao X, Jiang W, Li W, Zhu S, Liao C, et al. Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-kB signaling pathway and pyroptosis after secondary spinal cord injury. Journal of Neuroinflammation. 2020; 17: 90.